Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05216796 · ClinicalTrials.gov registry record · NA

Healthy Liver - Healthy Brain

A NA study of Metabolic Syndrome and Pre Diabetes, sponsored by University of Texas at Austin.

Completed
Registry status
NA
Development phase
55
Enrollment target
1
Study location

NCT05216796 is a NA study of Metabolic Syndrome and Pre Diabetes that has completed, run by University of Texas at Austin. The registered enrollment target is 55 participants, below the 1,204-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05216796, a NA study of Metabolic Syndrome and Pre Diabetes, has completed, sponsored by University of Texas at Austin.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target
1
Study location

Study Summary

People with liver disease report difficulties with attention and problem-solving skills. Diet plays an important role in the development of liver disease and/or pre-diabetes. The purpose of this study is to examine whether participation in a brief diet intervention (up to 3 weeks) can improve brain and liver health and function.

Interventions

  • BEHAVIORAL Diet Intervention

Study Locations (1)

Texas

  • University of Texas at Austin - Austin

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2022-05-18
Est. Completion 2024-09-01
Phase NA

Sponsor

University of Texas at Austin

257 total trials

What the Registry Record Tells You About NCT05216796

The ClinicalTrials.gov registry entry for NCT05216796 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,204-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (95% lower). The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Metabolic Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Diet Intervention is the first listed.

NCT05216796 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05216796 about?

NCT05216796 is a clinical study titled "Healthy Liver - Healthy Brain". People with liver disease report difficulties with attention and problem-solving skills. Diet plays an important role in the development of liver disease and/or pre-diabetes. The purpose of this study is to examine whether participation in a brief diet intervention (up to 3 weeks) can improve brain ...

What is the current status of trial NCT05216796?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2022-05-18. Estimated completion is 2024-09-01.

What conditions does trial NCT05216796 study?

This clinical trial studies the following conditions: Metabolic Syndrome, Pre Diabetes, Non-alcoholic Fatty Liver Disease, NAFLD.

What interventions are being tested in trial NCT05216796?

The interventions under investigation include: Diet Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05216796?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05216796 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.